Latest Schedule 13G passive stakes

Manulife Financial Corporation and its subsidiaries have filed an amendment to their Schedule 13G, updating beneficial ownership information for Eagle Bancorp Montana, Inc.

Manulife Financial Corporation and its subsidiaries have filed an amendment to their Schedule 13G, updating beneficial ownership information for Eagle Bancorp Montana, Inc.

Loomis Sayles & Co., L.P. has reported a beneficial ownership of 7.04% in SEI Investments Co. as of June 30, 2026.

Ameriprise Financial, Inc. and its subsidiary Columbia Management Investment Advisers, LLC have reported beneficial ownership of 6.7% of America's Car-Mart, Inc. common stock as of June 30, 2026.

Ameriprise Financial, Inc. and its subsidiary Columbia Management Investment Advisers, LLC have reported beneficial ownership of 6.7% of America's Car-Mart, Inc. common stock as of June 30, 2026.

Ameriprise Financial, Inc. has filed a Schedule 13G, reporting beneficial ownership of 7,659,376 shares of Babcock & Wilcox Enterprises, Inc. common stock, representing 5.1% of the class.

Ameriprise Financial, Inc. has filed a Schedule 13G, reporting beneficial ownership of 7,659,376 shares of Babcock & Wilcox Enterprises, Inc. common stock, representing 5.1% of the class.

T. Rowe Price Investment Management, Inc. has updated its beneficial ownership filing for Miami International Holdings, reporting a 5.3% stake.

T. Rowe Price Investment Management, Inc. has filed an amendment to its Schedule 13G, reporting a beneficial ownership of 3.7% in MACOM Technology Solutions Holdings Inc.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.0% of Expro Group Holdings NV's common stock as of June 30, 2026.

T. Rowe Price Investment Management, Inc. has disclosed beneficial ownership of 10.5% of Planet Fitness Inc.'s common stock as of June 30, 2026.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting a beneficial ownership of 15.3% in Shattuck Labs Inc. common stock as of June 30, 2026.

T. Rowe Price Investment Management, Inc. has amended its Schedule 13G filing to report a beneficial ownership of 18.1% in Aurora Innovation Inc. as of June 30, 2026.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 4.6% of Sportradar Group AG's common stock.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 1,568,820 shares, representing 8.6% of USCB Financial Holdings' common stock.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.9% of M-TRON INDUSTRIES INC's common stock as of June 30, 2026.

T. Rowe Price Investment Management, Inc. has updated its beneficial ownership filing for QuidelOrtho Corp., reporting a 2.6% stake.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.0% of Revvity Inc.'s common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed an amendment to its Schedule 13G, reporting its beneficial ownership of Repligen Corp. common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, disclosing a beneficial ownership of 5,428,244 shares, representing 4.9% of Quest Diagnostics Inc.'s common stock.

T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 6.6% of Descartes Systems Group's common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 2,222,444 shares, representing 6.2% of Novanta Inc.'s common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 12.5% of Expro Group Holdings NV's common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.8% of United States Antimony Corp.'s common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, disclosing beneficial ownership of 6.1% of Fulton Financial Corp.'s common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.0% of Celldex Therapeutics' common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 7.0% of Vicor Corp's common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has updated its Schedule 13G filing to reflect beneficial ownership of 5.2% of Hanover Insurance Group Inc.'s common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has disclosed beneficial ownership of 6.6% of SLM Corp's common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has reported a beneficial ownership of 5.3% in Build-A-Bear Workshop Inc., holding 669,597 shares.